1308849-97-9

Upstream product

• 1308849-96-8 (R)-4-(1-((4-(tert-butoxycarbonyl)morpholin-2-yl)methyl)-5-methyl-1H-benzo[d]imidazol-2-yl)-3,5-difluorobenzoic acid 
• 74-89-5 methylamine 
• 455-40-3 3,5-difluorobenzoic acid 
• 1308849-85-5 3,5-difluoro-4-formyl-N-methylbenzamide 
• 1308849-91-3 (S)-tert-butyl 2-((1,3-dioxoisoindolin-2-yl)methyl)morpholine-4-carboxylate 
• 446-11-7 4-fluoro-3-nitrotoluene 
• 135065-71-3 (R)-2-hydroxymethylmorpholine-4-carboxylic acid tert-butyl ester 
• 1074-82-4 potassium phtalimide 
• 1308849-95-7 (R)-tert-butyl 2-((2-amino-4-methylphenylamino)methyl)morpholine-4-carboxylate 
• 1308849-93-5 (R)-tert-butyl 2-((1,3-dioxoisoindolin-2-yl)methyl)morpholine-4-carboxylate 
• 1174913-80-4 tert-butyl (2R)-2-(aminomethyl)morpholine-4-carboxylate 
• 736990-88-8 3,5-difluoro-4-formylbenzoic acid 
• 606139-90-6 tert-butyl (2S)-2-{[(methylsulfonyl)oxy]methyl}morpholine-4-carboxylate 
• 135065-76-8 tert-butyl (2S)-2-(hydroxymethyl)morpholine-4-carboxylate 

Downstream Products

• 1308849-94-6 (R)-methyl 2-((2-(2,6-difluoro-4-(methylcarbamoyl)phenyl)-5-methyl-1H-benzo[d]imidazol-1-yl)methyl)morpholine-4-carboxylate 

Relevant academic research and scientific papers

COMBINATION THERAPIES FOR TREATING PAIN

This invention generally relates to a combination therapy comprising the use of a substituted benzoimidazole compound and a nonsteroidal anti-inflammatory drug (NSAID) or acetaminophen, and, in particular, to the use of methyl 2-((2-(2,6-difluoro-4- (meth

BENZOIMIDAZOLE COMPOUNDS AND USES THEREOF

This invention generally relates to substituted benzoimidazole compounds, particularly methyl 2-((2-(2,6-difluoro-4-(methylcarbamoyl)phenyl)-5-methyl-1H- benzo[d]imidazol-1-yl)methyl)morpholine-4-carboxylate and salts thereof. This invention also relates